The human secretome M Uhlén, MJ Karlsson, A Hober, AS Svensson, J Scheffel, D Kotol, ... Science signaling 12 (609), eaaz0274, 2019 | 329 | 2019 |
Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk K Tengvall, J Huang, C Hellström, P Kammer, M Biström, B Ayoglu, ... Proceedings of the National Academy of Sciences 116 (34), 16955-16960, 2019 | 163 | 2019 |
Spatiotemporal dissection of the cell cycle with single-cell proteogenomics D Mahdessian, AJ Cesnik, C Gnann, F Danielsson, L Stenström, M Arif, ... Nature 590 (7847), 649-654, 2021 | 128 | 2021 |
Affinity proteomics within rare diseases: a BIO‐NMD study for blood biomarkers of muscular dystrophies B Ayoglu, A Chaouch, H Lochmüller, L Politano, E Bertini, P Spitali, ... EMBO molecular medicine 6 (7), 918-936, 2014 | 126 | 2014 |
Clonal evolution of autoreactive germinal centers SE Degn, CE van der Poel#, DJ Firl#, B Ayoglu, FA Al Qureshah, G Bajic, ... Cell 170 (5), 913-926. e19, 2017 | 125 | 2017 |
Anoctamin 2 identified as an autoimmune target in multiple sclerosis B Ayoglu, N Mitsios, I Kockum, M Khademi, A Zandian, R Sjöberg, ... Proceedings of the National Academy of Sciences 113 (8), 2188-2193, 2016 | 114 | 2016 |
Autoantibody profiling in multiple sclerosis using arrays of human protein fragments B Ayoglu, A Häggmark, M Khademi, T Olsson, M Uhlen, JM Schwenk, ... Molecular & Cellular Proteomics 12 (9), 2657-2672, 2013 | 101 | 2013 |
Structural basis of cross‐reactivity of anti–citrullinated protein antibodies C Ge, B Xu, B Liang, E Lönnblom, SL Lundström, RA Zubarev, B Ayoglu, ... Arthritis & Rheumatology 71 (2), 210-221, 2019 | 88 | 2019 |
AIRE expression controls the peripheral selection of autoreactive B cells J Sng, B Ayoglu, JW Chen, JN Schickel, EMN Ferre, S Glauzy, ... Science immunology 4 (34), eaav6778, 2019 | 84 | 2019 |
Whole-proteome peptide microarrays for profiling autoantibody repertoires within multiple sclerosis and narcolepsy A Zandian, B Forsström, A Häggmark-Månberg, JM Schwenk, ... Journal of proteome research 16 (3), 1300-1314, 2017 | 74 | 2017 |
Exploration of high-density protein microarrays for antibody validation and autoimmunity profiling R Sjöberg, C Mattsson, E Andersson, C Hellström, M Uhlen, JM Schwenk, ... New biotechnology 33 (5), 582-592, 2016 | 70 | 2016 |
Systematic antibody and antigen-based proteomic profiling with microarrays B Ayoglu, A Häggmark, M Neiman, U Igel, M Uhlén, JM Schwenk, ... Expert review of molecular diagnostics 11 (2), 219-234, 2011 | 67 | 2011 |
Anti-citrullinated protein antibodies cause arthritis by cross-reactivity to joint cartilage C Ge, D Tong, B Liang, E Lönnblom, N Schneider, C Hagert, J Viljanen, ... JCI insight 2 (13), 2017 | 65 | 2017 |
Antigen arrays for profiling autoantibody repertoires B Ayoglu, JM Schwenk, P Nilsson Bioanalysis 8 (10), 1105-1126, 2016 | 59 | 2016 |
Affinity proteomic profiling of plasma, cerebrospinal fluid, and brain tissue within multiple sclerosis S Byström#, B Ayoglu#, A Häggmark, N Mitsios, MG Hong, K Drobin, ... Journal of proteome research 13 (11), 4607-4619, 2014 | 57 | 2014 |
Antibody‐based profiling of cerebrospinal fluid within multiple sclerosis A Häggmark, S Byström, B Ayoglu, U Qundos, M Uhlén, M Khademi, ... Proteomics 13 (15), 2256-2267, 2013 | 53 | 2013 |
Discovery of circulating proteins associated to knee radiographic osteoarthritis L Lourido, B Ayoglu, J Fernández-Tajes, N Oreiro, F Henjes, C Hellström, ... Scientific Reports 7 (1), 137, 2017 | 38 | 2017 |
Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy M Signorelli, B Ayoglu, C Johansson, H Lochmüller, V Straub, F Muntoni, ... Journal of cachexia, sarcopenia and muscle 11 (2), 505-517, 2020 | 34 | 2020 |
Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy K Strandberg, B Ayoglu, A Roos, M Reza, E Niks, M Signorelli, E Fasterius, ... Journal of neuromuscular diseases 7 (3), 231-246, 2020 | 26 | 2020 |
Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne A Lourbakos, N Yau, P De Bruijn, M Hiller, K Kozaczynska, ... Scientific reports 7 (1), 17888, 2017 | 26 | 2017 |